trending Market Intelligence /marketintelligence/en/news-insights/trending/6qqpu9d8mmpjmekfrmc5ja2 content esgSubNav
In This List

Leap Therapeutics raises $16.1M via common stock offering

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Leap Therapeutics raises $16.1M via common stock offering

Leap Therapeutics Inc. raised $16.1 million in gross proceeds from the sale of 2,146,667 common shares in an underwritten public offering.

The shares sold included 280,000 shares sold pursuant to the full exercise of the underwriters' option to buy additional shares.

Raymond James & Associates Inc. and Ladenburg Thalmann acted as book-running managers for the offering.